A 59-year-old man with type 2 diabetes, established coronary artery disease and an eGFR of 65 mL/min/1.73 m² has an HbA1c of 7.8% despite maximal tole...

Question

A 59-year-old man with type 2 diabetes, established coronary artery disease and an eGFR of 65 mL/min/1.73 m² has an HbA1c of 7.8% despite maximal tolerated metformin. According to Diabetes Canada guidelines, which additional agent is preferred to improve cardiovascular outcomes?

Accepted Answer

Add an SGLT2 inhibitor with demonstrated cardiovascular benefit.

Answer

Add a sulfonylurea such as glyburide.

Answer

Add acarbose.

Answer

Add basal insulin only.

Answer

Add pioglitazone.

ca-mccqe1 MCQ (SBA): Type 2 diabetes with cardiovascular disease

A 59-year-old man with type 2 diabetes, established coronary artery disease and an eGFR of 65 mL/min/1.73 m² has an HbA1c of 7.8% despite maximal tolerated metformin. According to Diabetes Canada guidelines, which additional agent is preferred to improve cardiovascular outcomes?